Randomized Controlled Trial Studying the Ameliorating Effects of Kaempferol Emulgel on Female Arousal Disorder and Sexual Dysfunction
Overview
- Phase
- Phase 1
- Intervention
- Kaempferol
- Conditions
- Female Sexual Dysfunction
- Sponsor
- Deraya University
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Female Sexual Function Index
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The aim of this study is to evaluate the quality of sexual life of females with sexual interest or arousal disorder before and after accurate application of a formulated emulgel made from natural ingredients, including kaempferol as an API
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women between the ages of 28 and 45
- •had regular periods and previous menstrual bleeding lasted between three and seven days
Exclusion Criteria
- •sensitivity to drug of therapy,
- •autoimmune illness,
- •smoking or drinking,
- •liver disease,
- •irregular menstruation
Arms & Interventions
Kaempferol group
Kaempferol gel received the vaginal gel containing antioxidant extract every day for seven days. Then, the treatment continued for two months, twice weekly
Intervention: Kaempferol
Placebo group
Plain formulation received the vaginal gel containing antioxidant extract every day for seven days. Then, the treatment continued for two months, twice weekly
Intervention: Kaempferol
Outcomes
Primary Outcomes
Female Sexual Function Index
Time Frame: two months
The FSFI comprises 19 questions of sexual function in six independent areas consisting of desire, arousal, lubrication, orgasm, sexual satisfaction , pain from sex.